Cargando…
Can PPSV-23 Vaccine Impact Exacerbations of Chronic Cough Symptoms and Medication Use in Younger Adult Asthmatics? A Clinical Question That Needs Answering
Symptoms of chronic cough (CC) from the airways are commonly treated with antibiotics, antitussives, bronchodilators, and steroids. There is a wide variability in treatment response, dependent on the exact cough etiology. Our case-series study was composed of 71 nonsmoking adults, 59 females, mean a...
Autores principales: | Lanz, Alessandra M., Chartrand, Esther, Eisenlohr, Claudia P., Lanz, Miguel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876381/ https://www.ncbi.nlm.nih.gov/pubmed/35214677 http://dx.doi.org/10.3390/vaccines10020219 |
Ejemplares similares
-
Impact of pneumococcal vaccine response on asthma exacerbation frequency in young children
por: Eisenlohr, Claudia P., et al.
Publicado: (2020) -
Can early intervention in pediatric asthma improve long‐term outcomes? A question that needs an answer
por: Lanz, Miguel J., et al.
Publicado: (2019) -
Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years
por: Chilson, Erica, et al.
Publicado: (2017) -
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
por: Migita, Kiyoshi, et al.
Publicado: (2015) -
Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients
por: Mülling, Nils, et al.
Publicado: (2023)